EGFR and lung adenocarcinoma: Only sporadic reports of histological transformation in lung cancer, such as small cell carcinoma evolving from lung adenocarcinoma, and breast cancer have been reported to be associated with chemotherapy combined with anti-EGFR TKIs, chemotherapy alone, immunotherapy, or hormone replacement therapy [6–9].